Rare diseases
Investigational molecules
Locations
172 conditions with trials, the busiest first
481 trials across Europe, recruiting first
Study on the Effects and Safety of ALXN2220 for Adults with Transthyretin Amyloid Cardiomyopathy
FranceStudy on Rosuvastatin and Atorvastatin for Preventing Heart Disease in Patients with High Genetic Risk
EstoniaStudy on How Tafamidis is Absorbed in the Blood of Healthy Adults with Transthyretin Amyloid Cardiomyopathy
BelgiumStudy on Vascular Dysfunction: Comparing Acetylcholine Chloride and Carbachol for Forearm Blood Flow Evaluation in Patients
DenmarkStudy on Manganese Uptake in Heart Failure Patients Using Mangafodipir Trisodium and Gadoteric Acid
NorwayStudy on the Effectiveness of Human Normal Immunoglobulin for Adults with Post-COVID-19 Postural Orthostatic Tachycardia Syndrome (POTS)
GermanyStudy of cannabidiol (CardiolRx) in patients with recurrent pericarditis after stopping IL-1 blocker treatment
GreeceStudy on the Effect of Adrenaline, Vasopressin, and Steroids on Survival in Cardiac Arrest Patients
SwedenStudy on Flecainide and Amiodarone for Treating Atrial Fibrillation in Patients with Coronary Artery Disease and Ejection Fraction Over 35%
GreeceStudy of Modified Anti-Platelet Therapy with Prasugrel, Ticagrelor, and Clopidogrel in Heart Attack Patients Undergoing Complete Revascularization
ItalyStudy of Levosimendan and Glucose Monohydrate for Patients with Low Ejection Fraction Takotsubo Syndrome
PolandStudy of Allopurinol to Reduce Cardiovascular Events in High-Risk Patients with Heart Disease and Long-COVID Syndrome
PolandThe therapies tested most often in Cardiac disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
